| Bioactivity | LY3154885 is an orally active dopamine D1 receptor positive allosteric modulator (PAM). LY3154885 has an improved drug-drug interactions (DDI) risk profile[1]. |
| Name | LY3154885 |
| CAS | 2379422-72-5 |
| Formula | C23H23Cl2N3O2 |
| Molar Mass | 444.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Junliang Hao, et al. Synthesis and Preclinical Characterization of LY3154885, a Human Dopamine D1 Receptor Positive Allosteric Modulator with an Improved Nonclinical Drug-Drug Interaction Risk Profile. J Med Chem. 2022 Mar 10;65(5):3786-3797. |
LY3154885
CAS: 2379422-72-5 F: C23H23Cl2N3O2 W: 444.35
LY3154885 is an orally active dopamine D1 receptor positive allosteric modulator (PAM). LY3154885 has an improved drug-d
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.